Cargando…

Idiopathic erythema multiforme: Evidence of underlying Janus kinase–signal transducer and activator of transcription activation and successful treatment with tofacitinib

Detalles Bibliográficos
Autores principales:	Damsky, William, King, Brett A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2016
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5161778/ https://www.ncbi.nlm.nih.gov/pubmed/28004029 http://dx.doi.org/10.1016/j.jdcr.2016.10.009

Ejemplares similares

Treatment of cutaneous sarcoidosis with tofacitinib: A case report and review of evidence for Janus kinase inhibition in sarcoidosis
por: Talty, Ronan, et al.
Publicado: (2021)

Treatment of generalized deep morphea and eosinophilic fasciitis with the Janus kinase inhibitor tofacitinib
por: Kim, Sa Rang, et al.
Publicado: (2018)

The Effects of Tofacitinib-Mediated Janus Kinase/Signal Transducers and Activators of the Transcription Signal Pathway Inhibition on Collagen Biosynthesis in Hepatic and Skin Fibroblast Cell Culture
por: ŞAHİN, Mehtap, et al.
Publicado: (2020)

Role of Janus kinase 1 and signal transducer and activator of transcription 3 in vitiligo
por: Samaka, Rehab M, et al.
Publicado: (2019)

Treatment of necrobiosis lipoidica with combination Janus kinase inhibition and intralesional corticosteroid
por: Damsky, William, et al.
Publicado: (2020)

Reply: Calm before the storm: Understanding the role of Janus kinase inhibitors in COVID-19
por: Peterson, Danielle, et al.
Publicado: (2020)

Janus kinases and signal transducers and activators of transcription: their roles in cytokine signaling, development and immunoregulation
por: Ortmann, Robert A, et al.
Publicado: (2000)

Role of Janus Kinase/Signal Transducers and Activators of Transcription in the Pathogenesis of Pancreatitis and Pancreatic Cancer
por: Yu, Ji Hoon, et al.
Publicado: (2012)

Treatment of granuloma annulare with tofacitinib 2% ointment
por: Damsky, William, et al.
Publicado: (2019)

Refractory case of ulcerative colitis with idiopathic thrombocytopenic purpura successfully treated by Janus kinase inhibitor tofacitinib: A case report
por: Komeda, Yoriaki, et al.
Publicado: (2020)

Immunohistochemical study of janus kinase 1/signal transducer and activator of transcription 3 in psoriasis vulgaris
por: Farag, Azza Gaber Antar, et al.
Publicado: (2019)

Sisaipho alopecia areata treated with tofacitinib and oral minoxidil
por: Talty, Ronan, et al.
Publicado: (2022)

The use of Janus kinase inhibitors in the time of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
por: Peterson, Danielle, et al.
Publicado: (2020)

Under-reported Finding in Acral Erythema Multiforme
por: Peña-Romero, Adriana G, et al.
Publicado: (2015)

Treatment of Multiorgan Sarcoidosis With Tofacitinib
por: Damsky, William, et al.
Publicado: (2020)

Oral Janus Kinase Inhibitor for the Treatment of Rheumatoid Arthritis: Tofacitinib
por: Ni, Han, et al.
Publicado: (2013)

Insights into the Binding Recognition and Susceptibility of Tofacitinib toward Janus Kinases
por: Sanachai, Kamonpan, et al.
Publicado: (2020)

Enhanced Expression of Janus Kinase–Signal Transducer and Activator of Transcription Pathway Members in Human Diabetic Nephropathy
por: Berthier, Celine C., et al.
Publicado: (2009)

Atypical erythema multiforme
por: Elfatoiki, Fatima Zahra, et al.
Publicado: (2015)

Dermoscopy of erythema multiforme
por: Kaliyadan, Feroze
Publicado: (2017)

Interplay between Janus Kinase/Signal Transducer and Activator of Transcription Signaling Activated by Type I Interferons and Viral Antagonism
por: Nan, Yuchen, et al.
Publicado: (2017)

Ras and Signal Transducer and Activator of Transcription (STAT) Are Essential and Sufficient Downstream Components of Janus Kinases in Cell Proliferation
por: Mizuguchi, Rumiko, et al.
Publicado: (2000)

Azeliragon ameliorates Alzheimer's disease via the Janus tyrosine kinase and signal transducer and activator of transcription signaling pathway
por: Yang, Lijuan, et al.
Publicado: (2021)

Baricitinib Ameliorates Experimental Autoimmune Encephalomyelitis by Modulating the Janus Kinase/Signal Transducer and Activator of Transcription Signaling Pathway
por: Dang, Chun, et al.
Publicado: (2021)

Refractory Takayasu arteritis responding to the oral Janus kinase inhibitor, tofacitinib
por: Yamamura, Yuriko, et al.
Publicado: (2019)

Impact of Janus Kinase Inhibition with Tofacitinib on Fundamental Processes of Bone Healing
por: Gaber, Timo, et al.
Publicado: (2020)

Erythema multiforme and erythema nodosum lesions with cervical lymphadenopathy
por: Muslu, Ümran, et al.
Publicado: (2017)

Herpes associated erythema multiforme
por: Kamala, K. A., et al.
Publicado: (2011)

Ciprofloxacin-induced erythema multiforme
por: Shilpashree, H. S., et al.
Publicado: (2012)

Bupropion-Induced Erythema Multiforme
por: Evrensel, Alper, et al.
Publicado: (2015)

Erythema multiforme induced by regorafenib
por: Matsunaga, Mototsugu, et al.
Publicado: (2017)

Hydroxychloroquine‐induced erythema multiforme
por: Koumaki, Dimitra, et al.
Publicado: (2020)

Erythema multiforme provoked by radiotherapy
por: Machoń, Natalia Joanna, et al.
Publicado: (2023)

Drug-Induced Erythema Multiforme
por: Shivhare, Peeyush, et al.
Publicado: (2023)

Drug induced oral erythema multiforme: A rare and less recognized variant of erythema multiforme
por: Joseph, T Isaac, et al.
Publicado: (2012)

Targeting Janus Kinases and Signal Transducer and Activator of Transcription 3 To Treat Inflammation, Fibrosis, and Cancer: Rationale, Progress, and Caution
por: Bharadwaj, Uddalak, et al.
Publicado: (2020)

Effects of Diabetes Mellitus on the Disposition of Tofacitinib, a Janus Kinase Inhibitor, in Rats
por: Gwak, Eun Hye, et al.
Publicado: (2020)

Topical Tofacitinib: A Janus Kinase Inhibitor for the Treatment of Vitiligo in an Adolescent Patient
por: Berbert Ferreira, Sineida, et al.
Publicado: (2021)

Acute onset of necrolytic migratory erythema mimicking an erythema multiforme
por: Juśko, Natalia, et al.
Publicado: (2020)

Anticancer Activity of Tubulosine through Suppression of Interleukin-6-Induced Janus Kinase 2/Signal Transducer and Activation of Transcription 3 Signaling
por: Kim, Byung-Hak, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_td8mriaqk2veb5fgt0r2hkr5kg